PEP protocol

chemotherapy protocol consisting of cisplatin, etoposide and peplomycin; used in treatment of refractory rhabdomyosarcoma of the prostate and testicular teratoma

Also Known As:

EBCi regimen

Therapeutics: 1158551
- Drug Therapy: 293145
  - Combination Drug Therapy: 12066
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - PEP protocol: 8
  - Antineoplastic Protocols: 55
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - PEP protocol: 8
- Clinical Protocols
  - Antineoplastic Protocols: 55
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - PEP protocol: 8
Inorganic Chemicals: 9
- Platinum Compounds: 758
  - Cisplatin: 46373
    - PEP protocol: 8
- Nitrogen Compounds: 67
  - Cisplatin: 46373
    - PEP protocol: 8
- Chlorine Compounds: 8
  - Cisplatin: 46373
    - PEP protocol: 8
Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Polycyclic Aromatic Hydrocarbons: 2020
        Naphthalenes: 18
        Tetrahydronaphthalenes: 1
        Podophyllotoxin: 562
        Etoposide: 10706
        PEP protocol: 8
Polycyclic Compounds: 6
- Polycyclic Aromatic Hydrocarbons: 2020
  - Naphthalenes: 18
    - Tetrahydronaphthalenes: 1
      - Podophyllotoxin: 562
        Etoposide: 10706
        PEP protocol: 8
Carbohydrates: 22023
- Glycosides: 2119
  - Glucosides: 639
    - Etoposide: 10706
      - PEP protocol: 8
- Glycoconjugates: 1353
  - Glycopeptides: 1928
    - Bleomycin: 9833
      - Peplomycin: 343
        PEP protocol: 8
Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Glycopeptides: 1928
    - Bleomycin: 9833
      - Peplomycin: 343
        PEP protocol: 8

Pamela J Wilson Selected Research

Pamela J Wilson Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure